Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Krzysztof Jóźwiak
Angiotensin II Type 1 Receptor Blockers Inhibit KAT II Activity in the Brain—Its Possible Clinical Applications
Neurotoxicity Research
Neuroscience
Toxicology
Related publications
The Angiotensin II Type 2 Receptor in the Brain
JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal Medicine
Endocrinology
Polymorphisms of the Angiotensin II Type 1 Receptor Gene Affect Antihypertensive Response to Angiotensin Receptor Blockers in Hypertensive Chinese
Genetics and Molecular Research
Medicine
Genetics
Molecular Biology
The Angiotensin II Type 1 Receptor and Receptor-Associated Proteins
Cell Research
Cell Biology
Molecular Biology
The Effect of Angiotensin II Receptor Blockers on Hyperuricemia
Therapeutic Advances in Chronic Disease
Medicine
Regulation of Angiotensin II Type 1 Receptor mRNA and Protein in Angiotensin II Induced Hypertension
Hypertension
Internal Medicine
Angiotensin II Upregulates Acyl-CoA:Cholesterol Acyltransferase-1 via the Angiotensin II Type 1 Receptor in Human Monocyte-Macrophages
Hypertension Research
Internal Medicine
Cardiovascular Medicine
Physiology
Cardiology
Angiotensin II Type-1 Receptor Blockers Enhance the Effects of Bevacizumab-Based Chemotherapy in Metastatic Colorectal Cancer Patients
Molecular and Clinical Oncology
Cancer Research
Oncology
Delivery of Angiotensin II Type 1 Receptor Antisense Inhibits Angiotensin Action in Neurons From Hypertensive Rat Brain.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Organoprotecive Effects of Angiotensin II Receptor Blockers in Patients With Type 2 Diabetes Mellitus
Diabetes Mellitus
Internal Medicine
Endocrinology
Metabolism
Diabetes